Filing Details

Accession Number:
0001104659-21-087298
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2021-06-30 12:28:12
Reporting Period:
2021-06-15
Accepted Time:
2021-06-30 12:28:12
Original Submission Date:
2021-06-17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613859 Pra Health Sciences Inc. PRAH Services-Commercial Physical & Biological Research (8731) 463640387
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1738327 J. Michael Bonello C/O Pra Health Sciences, Inc
4130 Parklake Avenue, Suite 400
Raleigh NC 27612
Evp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-16 6,589 $166.43 5,275 No 4 S Direct
Common Stock Disposition 2021-06-16 600 $167.47 4,675 No 4 S Direct
Common Stock Disposition 2021-06-16 195 $168.19 4,480 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.07 to $166.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3) and (4) of this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.11 to $167.96, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.11 to $168.26, inclusive.
  5. The number of shares reported in Column 5 reflects the number of shares beneficially owned by the reporting person as of the filing date of this Form 4, which reflects the transactions reported on the Form 4 filed by the reporting person on June 21, 2021.